The content on this site is intended for healthcare professionals only
Discusses the research presented on circulating tumour cells at ECCO 15 - ESMO 34, Berlin 2009.
New classification for identifying HR myeloma based on cytogenetic abnormalities
Tele-mentoring: Impact of project ECHO
Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
Choosing the right patients for transplant
Choosing Wisely in endometrial & cervix cancers: Medical therapy
Cancer mutation prediction using artificial intelligence
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Understanding patient factors and barriers in oncology treatment
Hormonal receptor positive breast cancer adjuvant and metastatic indications
